HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch

HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch

Highlights: HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switchПодробнее

Highlights: HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch

Overview of 2nd line treatment options in advanced HCCПодробнее

Overview of 2nd line treatment options in advanced HCC

A new era in treating patients with advanced HCCПодробнее

A new era in treating patients with advanced HCC

Second-Line Therapy in Advanced HCCПодробнее

Second-Line Therapy in Advanced HCC

Approaching Second-Line Therapy for Advanced HCCПодробнее

Approaching Second-Line Therapy for Advanced HCC

A New Era in Treating Patients with Advanced HCC: 2nd line treatment selection and when to switch?Подробнее

A New Era in Treating Patients with Advanced HCC: 2nd line treatment selection and when to switch?

Advanced HCC: When to switch to 2nd line treatment - a patient case videoПодробнее

Advanced HCC: When to switch to 2nd line treatment - a patient case video

2nd line treatment in advanced HCC and when to switchПодробнее

2nd line treatment in advanced HCC and when to switch

Approaching Sequencing in HCC: Second-Line TherapyПодробнее

Approaching Sequencing in HCC: Second-Line Therapy

Emerging Second-Line Therapies in HCCПодробнее

Emerging Second-Line Therapies in HCC

Novel developments in HCC treatmentПодробнее

Novel developments in HCC treatment

First-Line Therapy in Advanced HCCПодробнее

First-Line Therapy in Advanced HCC

KEYNOTE-224: Second-line pembrolizumab for advanced hepatocellular carcinomaПодробнее

KEYNOTE-224: Second-line pembrolizumab for advanced hepatocellular carcinoma

Immunotherapy in Second-Line Metastatic HCCПодробнее

Immunotherapy in Second-Line Metastatic HCC

Second-LineTreatment for HCCПодробнее

Second-LineTreatment for HCC

Practice-Changing Updates in the Second-Line Treatment of Gastric/GEJ Cancer (2 of 2)Подробнее

Practice-Changing Updates in the Second-Line Treatment of Gastric/GEJ Cancer (2 of 2)